The effect of immunosuppressive therapy on cardiac involvements in anti‐mitochondrial antibody‐positive myositis

The effect of immunosuppressive therapy on cardiac involvements in anti‐mitochondrial antibody‐positive myositis

Abstract Aims Anti‐mitochondrial antibody (AMA)‐positive myositis is frequently associated with various cardiac involvements, such as arrhythmia and left ventricular (LV) dysfunction. However, the efficacy of immunosuppressive therapy in these complications remains unknown. This study aimed to inves...

Full description

Bibliographic Details
Main Authors: Satoshi Bujo, Eisuke Amiya, Meiko Hashimoto Maeda, Junichi Ishida, Masaru Hatano, Masato Ishizuka, Masae Uehara, Tsukasa Oshima, Toshiya Kojima, Koki Nakanishi, Masao Daimon, Jun Shimizu, Tatsushi Toda, Issei Komuro
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:ESC Heart Failure
Subjects:
Anti‐mitochondrial antibody
Myositis
Cardiac involvement
Immunosuppressive therapy
Online Access:https://doi.org/10.1002/ehf2.14138

Internet

https://doi.org/10.1002/ehf2.14138

Similar Items